NR 508 (NR 508 -Week 2 Study Guide.)

NR 508 Quiz questions and answers( A+ GRADED 100% VERIFIED) LATEST 2023

NR 508 Final Exam Practice Q&As with Rationale 1. A patient who has diabetes reports intense discomfort when needing to void. A urinalysis is normal. To treat this, the primary care NP should consider prescribing: oxybutynin chloride (Ditropan XL). This patient is describing urge incontinence, or overactive bladder, which occurs when the detrusor muscle is hyperactive, causing an intense urge to void before the bladder is full. Urge incontinence is associated with many conditions, incl...

NR 508 Final Exam Practice Q&As with Rationale 1. A patient who has diabetes reports intense discomfort when needing to void. A urinalysis is normal. To treat this, the primary care NP should consider prescribing: oxybutynin chloride (Ditropan XL). This patient is describing urge incontinence, or overactive bladder, which occurs when the detrusor muscle is hyperactive, causing an intense urge to void before the bladder is full. Urge incontinence is associated with many conditions, incl...

NR 508 -Pharm Midterm Outline + chart/NR 508 -Pharm Midterm Outline + chart.

NR 508 - Final Exam Study Guide ( 100% correct)/NR 508 - Final Exam Study Guide ( 100% correct).

NR 508 - Midterm Study Guide./NR 508 - Midterm Study Guide.

NR 508 Final Exam NR508 Final Exam NR 508 Final Exam NR508 Final Exam NR 508 Final Exam NR508 Final Exam NR 508 Final Exam NR508 Final Exam

Question 1 2 / 2 pts A patient has three consecutive blood pressure readings of 140/95 mm Hg. The patient’s body mass index is 24. A fasting plasma glucose is 100 mg/dL. Creatinine clearance and cholesterol tests are normal. The primary care NP should order: a β-blocker. an angiotensin-converting enzyme inhibitor. a thiazide diuretic. dietary and lifestyle changes. Question 2 2 / 2 pts An African-American patient is taking captopril (Capoten) 25 mg twice daily. When ...

A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should: change the atorvastatin dose to 15 mg twice daily. change the patient’s medication to cholestyramine (Questran). Correct! add ezetimibe (Zetia) and low...